AAPL354.88-0.48 (-0.14%) ▼|ABBV294.45-0.53 (-0.18%) ▼|ABT107.25-2.04 (-1.87%) ▼|ACN249.95-3.71 (-1.46%) ▼|ADBE238.54+0.94 (+0.40%) ▲|AMAT380.95-14.13 (-3.58%) ▼|AMD585.30+32.40 (+5.86%) ▲|AMGN467.06-1.05 (-0.22%) ▼|AMT189.79-0.45 (-0.24%) ▼|AMZN267.44+1.27 (+0.48%) ▲|AVGO364.36+19.14 (+5.54%) ▲|AXP318.06-5.05 (-1.56%) ▼|BA171.55-2.99 (-1.71%) ▼|BAC50.51-0.16 (-0.32%) ▼|BKNG161.20+0.99 (+0.62%) ▲|BLK1,216.61-9.70 (-0.79%) ▼|BMY62.32-0.59 (-0.94%) ▼|BNY152.79+0.10 (+0.07%) ▲|BRK-B589.83+1.59 (+0.27%) ▲|C124.06-0.15 (-0.12%) ▼|CAT605.28+3.67 (+0.61%) ▲|CL97.90-0.10 (-0.10%) ▼|CMCSA24.80-0.22 (-0.88%) ▼|COF193.60-3.51 (-1.78%) ▼|COP140.06+2.20 (+1.60%) ▲|COST1,092.21+4.60 (+0.42%) ▲|CRM217.57-0.44 (-0.20%) ▼|CSCO102.01+1.25 (+1.24%) ▲|CVS89.79+0.27 (+0.30%) ▲|CVX216.35+3.07 (+1.44%) ▲|DE678.79-12.96 (-1.87%) ▼|DHR232.16-3.15 (-1.34%) ▼|DIS118.23-1.42 (-1.19%) ▼|DUK128.59-0.18 (-0.14%) ▼|EMR166.92-0.14 (-0.08%) ▼|FDX319.30-3.33 (-1.03%) ▼|GD363.07-4.15 (-1.13%) ▼|GE330.86-11.89 (-3.47%) ▼|GEV818.49+10.25 (+1.27%) ▲|GILD167.95-1.78 (-1.05%) ▼|GM86.25-2.65 (-2.98%) ▼|GOOG295.35+4.72 (+1.62%) ▲|GOOGL298.70+5.25 (+1.79%) ▲|GS913.60-13.21 (-1.43%) ▼|HD348.26-3.05 (-0.87%) ▼|HON223.45-4.19 (-1.84%) ▼|IBM244.67-3.55 (-1.43%) ▼|INTC61.20-1.27 (-2.03%) ▼|INTU340.17-2.47 (-0.72%) ▼|ISRG439.89-9.64 (-2.14%) ▼|JNJ283.52+3.11 (+1.11%) ▲|JPM342.82-0.57 (-0.17%) ▼|KO97.44-0.13 (-0.13%) ▼|LIN522.49-4.06 (-0.77%) ▼|LLY1,427.28-10.01 (-0.70%) ▼|LMT604.09-5.96 (-0.98%) ▼|LOW227.46-4.14 (-1.79%) ▼|LRCX233.78-2.10 (-0.89%) ▼|MA652.60-8.13 (-1.23%) ▼|MCD273.63-1.17 (-0.43%) ▼|MDLZ66.56-0.14 (-0.21%) ▼|MDT100.99-0.62 (-0.61%) ▼|META623.61-5.16 (-0.82%) ▼|MMM186.24-2.64 (-1.40%) ▼|MO77.92+0.53 (+0.68%) ▲|MRK146.95-0.23 (-0.16%) ▼|MS189.17-1.44 (-0.76%) ▼|MSFT523.00+1.88 (+0.36%) ▲|MU798.44-12.86 (-1.59%) ▼|NEE85.29-0.70 (-0.81%) ▼|NFLX62.69-1.85 (-2.87%) ▼|NKE37.76-0.56 (-1.46%) ▼|NOW100.66-2.10 (-2.04%) ▼|NVDA166.19-7.54 (-4.34%) ▼|ORCL127.11-1.27 (-0.99%) ▼|PEP142.26-1.68 (-1.17%) ▼|PFE28.83-0.62 (-2.11%) ▼|PG168.03+0.36 (+0.21%) ▲|PLTR171.58-0.82 (-0.48%) ▼|PM196.66+0.31 (+0.16%) ▲|QCOM177.14+0.57 (+0.32%) ▲|RTX198.36-2.93 (-1.46%) ▼|SBUX107.26-2.63 (-2.39%) ▼|SCHW91.72-1.06 (-1.14%) ▼|SO92.47-1.37 (-1.46%) ▼|SPG233.61-1.14 (-0.49%) ▼|T22.18-0.08 (-0.36%) ▼|TMO699.44-18.27 (-2.55%) ▼|TMUS171.03-1.13 (-0.66%) ▼|TSLA397.45+6.63 (+1.70%) ▲|TXN312.48+2.67 (+0.86%) ▲|UBER69.12-1.56 (-2.21%) ▼|UNH405.13+2.19 (+0.54%) ▲|UNP304.20+2.09 (+0.69%) ▲|UPS110.38-2.07 (-1.84%) ▼|USB60.47-0.23 (-0.38%) ▼|V420.31-5.24 (-1.23%) ▼|VZ46.55-0.05 (-0.11%) ▼|WFC85.76-0.04 (-0.05%) ▼|WMT126.19+0.52 (+0.41%) ▲|XOM169.78+3.07 (+1.84%) ▲|AAPL354.88-0.48 (-0.14%) ▼|ABBV294.45-0.53 (-0.18%) ▼|ABT107.25-2.04 (-1.87%) ▼|ACN249.95-3.71 (-1.46%) ▼|ADBE238.54+0.94 (+0.40%) ▲|AMAT380.95-14.13 (-3.58%) ▼|AMD585.30+32.40 (+5.86%) ▲|AMGN467.06-1.05 (-0.22%) ▼|AMT189.79-0.45 (-0.24%) ▼|AMZN267.44+1.27 (+0.48%) ▲|AVGO364.36+19.14 (+5.54%) ▲|AXP318.06-5.05 (-1.56%) ▼|BA171.55-2.99 (-1.71%) ▼|BAC50.51-0.16 (-0.32%) ▼|BKNG161.20+0.99 (+0.62%) ▲|BLK1,216.61-9.70 (-0.79%) ▼|BMY62.32-0.59 (-0.94%) ▼|BNY152.79+0.10 (+0.07%) ▲|BRK-B589.83+1.59 (+0.27%) ▲|C124.06-0.15 (-0.12%) ▼|CAT605.28+3.67 (+0.61%) ▲|CL97.90-0.10 (-0.10%) ▼|CMCSA24.80-0.22 (-0.88%) ▼|COF193.60-3.51 (-1.78%) ▼|COP140.06+2.20 (+1.60%) ▲|COST1,092.21+4.60 (+0.42%) ▲|CRM217.57-0.44 (-0.20%) ▼|CSCO102.01+1.25 (+1.24%) ▲|CVS89.79+0.27 (+0.30%) ▲|CVX216.35+3.07 (+1.44%) ▲|DE678.79-12.96 (-1.87%) ▼|DHR232.16-3.15 (-1.34%) ▼|DIS118.23-1.42 (-1.19%) ▼|DUK128.59-0.18 (-0.14%) ▼|EMR166.92-0.14 (-0.08%) ▼|FDX319.30-3.33 (-1.03%) ▼|GD363.07-4.15 (-1.13%) ▼|GE330.86-11.89 (-3.47%) ▼|GEV818.49+10.25 (+1.27%) ▲|GILD167.95-1.78 (-1.05%) ▼|GM86.25-2.65 (-2.98%) ▼|GOOG295.35+4.72 (+1.62%) ▲|GOOGL298.70+5.25 (+1.79%) ▲|GS913.60-13.21 (-1.43%) ▼|HD348.26-3.05 (-0.87%) ▼|HON223.45-4.19 (-1.84%) ▼|IBM244.67-3.55 (-1.43%) ▼|INTC61.20-1.27 (-2.03%) ▼|INTU340.17-2.47 (-0.72%) ▼|ISRG439.89-9.64 (-2.14%) ▼|JNJ283.52+3.11 (+1.11%) ▲|JPM342.82-0.57 (-0.17%) ▼|KO97.44-0.13 (-0.13%) ▼|LIN522.49-4.06 (-0.77%) ▼|LLY1,427.28-10.01 (-0.70%) ▼|LMT604.09-5.96 (-0.98%) ▼|LOW227.46-4.14 (-1.79%) ▼|LRCX233.78-2.10 (-0.89%) ▼|MA652.60-8.13 (-1.23%) ▼|MCD273.63-1.17 (-0.43%) ▼|MDLZ66.56-0.14 (-0.21%) ▼|MDT100.99-0.62 (-0.61%) ▼|META623.61-5.16 (-0.82%) ▼|MMM186.24-2.64 (-1.40%) ▼|MO77.92+0.53 (+0.68%) ▲|MRK146.95-0.23 (-0.16%) ▼|MS189.17-1.44 (-0.76%) ▼|MSFT523.00+1.88 (+0.36%) ▲|MU798.44-12.86 (-1.59%) ▼|NEE85.29-0.70 (-0.81%) ▼|NFLX62.69-1.85 (-2.87%) ▼|NKE37.76-0.56 (-1.46%) ▼|NOW100.66-2.10 (-2.04%) ▼|NVDA166.19-7.54 (-4.34%) ▼|ORCL127.11-1.27 (-0.99%) ▼|PEP142.26-1.68 (-1.17%) ▼|PFE28.83-0.62 (-2.11%) ▼|PG168.03+0.36 (+0.21%) ▲|PLTR171.58-0.82 (-0.48%) ▼|PM196.66+0.31 (+0.16%) ▲|QCOM177.14+0.57 (+0.32%) ▲|RTX198.36-2.93 (-1.46%) ▼|SBUX107.26-2.63 (-2.39%) ▼|SCHW91.72-1.06 (-1.14%) ▼|SO92.47-1.37 (-1.46%) ▼|SPG233.61-1.14 (-0.49%) ▼|T22.18-0.08 (-0.36%) ▼|TMO699.44-18.27 (-2.55%) ▼|TMUS171.03-1.13 (-0.66%) ▼|TSLA397.45+6.63 (+1.70%) ▲|TXN312.48+2.67 (+0.86%) ▲|UBER69.12-1.56 (-2.21%) ▼|UNH405.13+2.19 (+0.54%) ▲|UNP304.20+2.09 (+0.69%) ▲|UPS110.38-2.07 (-1.84%) ▼|USB60.47-0.23 (-0.38%) ▼|V420.31-5.24 (-1.23%) ▼|VZ46.55-0.05 (-0.11%) ▼|WFC85.76-0.04 (-0.05%) ▼|WMT126.19+0.52 (+0.41%) ▲|XOM169.78+3.07 (+1.84%) ▲|
4.2 C
New York
Friday, November 13, 2026

Tag: development

newsFORsourcecompanycontentinformationreleases1IT

Praxis Precision Medicines to Participate in Upcoming Fireside Chat

BOSTON, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that CEO Marcio Souza will be participating a virtual fireside chat hosted by Truist Securities analyst Joon Lee on August 5, 2025 at 10:00amEST.

METiS Technologies Closes RMB 400 Million Series D Financing to Power Beijing’s Biopharmaceutical Innovation Engine

BEIJING, China, Aug. 4, 2025 /PRNewswire/ -- METiS Technologies, a global leader in AI-driven nanodelivery innovation, today announced the successful completion of its RMB...

Innovent Receives U.S. FDA Approval for IND Application of Oral GLP-1R Agonist IBI3032

SAN FRANCISCO and SUZHOU, China, Aug. 4, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality...

Lightium, MPI Corporation, and Axiomatic_AI Announce Strategic Partnership to Revolutionize Photonic Integrated Circuit (PIC) Device Testing with AI-Driven Solutions

ZURICH and HSINCHU and BOSTON, Aug. 4, 2025 /PRNewswire/ -- Lightium AG, MPI Corporation, and Axiomatic_AI Inc. have entered into a Memorandum of Understanding...

SIGGRAPH 2025 Announces Keynote Presentations Featuring Top Technological Marvels Shaping Our Trajectory Toward a Better Future

Topics Ranging From AI Algorithms to the Search for Life in the Universe Take Center Stage With Speakers From Adobe Research, Autodesk, NVIDIA, and...

CYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIB

         - Biliary tract cancer (BTC) or cholangiocarcinoma is an aggressive tumor with poor prognosis -

iSpecimen Inc. Announces Closing of Approximately $1.75 Million Private Placement Priced At-the-Market

WOBURN, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it closed its previously announced private placement pursuant to a securities purchase agreement with accredited investors for aggregate gross proceeds of approximately $1.75 million, before deducting fees to the placement agent and other offering expenses payable by the Company. The Company intends to use the net proceeds from the offering to pay $500,000 for marketing and advertising services to be provided by IR Agency LLC, and the remainder for working capital and general corporate purposes.

XKIG Acquires River City Construction

Acquisition Offers Significant Opportunity for Future Growth  NORFOLK, Va., Aug. 4, 2025 /PRNewswire/ -- Today, XKIG, a national leader in critical infrastructure services for the power...

Interstitial Cystitis Market to Grow Rapidly at a CAGR of 4% During the Study Period (2020-2034) | DelveInsight

The interstitial cystitis market is limited by a few approved treatments and high unmet need. However, pipeline innovation and rising awareness are expected to...

Interstitial Cystitis Market to Grow Rapidly at a CAGR of 4% During the Study Period (2020-2034) | DelveInsight

The interstitial cystitis market is limited by a few approved treatments and high unmet need. However, pipeline innovation and rising awareness are expected to...

LSL PHARMA GROUP ANNOUNCES THE COMPLETION OF EARLY REDEMPTION OF ALL 11% UNSECURED CONVERTIBLE DEBENTURES

BOUCHERVILLE, QC, Aug. 4, 2025 /CNW/ - LSL PHARMA GROUP INC. (TSXV: LSL) ("LSL Pharma" or the "Corporation"), a Canadian integrated pharmaceutical company, today announced...

Granite and CEO Rob Hale Make Largest Team Donation in Pan-Mass Challenge History

Granite's "B.A.'s Brigade" Honors Cherished Colleague by Raising $3.6 Million QUINCY, Mass., Aug. 4, 2025 /PRNewswire/ -- Granite Telecommunications, led by CEO Rob Hale, has made...

Resecurity Partners with Duke University Masters of Engineering in Cybersecurity to Bolster Cyber Intelligence Education

LOS ANGELES, Aug. 4, 2025 /PRNewswire/ -- Resecurity®, Inc., a global leader in cyber threat intelligence and security solutions, today announces an educational collaboration...

Fortistar and Epic Star Energy Acquire Renewable Energy Portfolio from HEI Subsidiary

HONOLULU, Aug. 4, 2025 /PRNewswire/ -- Fortistar and Epic Star Energy ("Epic Star") announced the acquisition of a renewable energy portfolio from Pacific Current,...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsDevelopment

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers